207 related articles for article (PubMed ID: 2969083)
1. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis.
Invernizzi RW; Cervo L; Samanin R
Neuropharmacology; 1988 May; 27(5):515-8. PubMed ID: 2969083
[TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
Cervo L; Grignaschi G; Samanin R
Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
[TBL] [Abstract][Full Text] [Related]
3. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons.
Bendotti C; Samanin R
Eur J Pharmacol; 1986 Feb; 121(1):147-50. PubMed ID: 2937644
[TBL] [Abstract][Full Text] [Related]
4. Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist.
Cervo L; Samanin R
Eur J Pharmacol; 1987 Dec; 144(2):223-9. PubMed ID: 2963752
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.
Martin P; Beninger RJ; Hamon M; Puech AJ
Behav Brain Res; 1990 May; 38(2):135-44. PubMed ID: 2141988
[TBL] [Abstract][Full Text] [Related]
6. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.
Carli M; Samanin R
Psychopharmacology (Berl); 1988; 94(1):84-91. PubMed ID: 2894704
[TBL] [Abstract][Full Text] [Related]
7. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity.
Hillegaart V; Hjorth S
Eur J Pharmacol; 1989 Jan; 160(2):303-7. PubMed ID: 2527161
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor blockade in nucleus accumbens or caudate nucleus differentially affects feeding induced by 8-OH-DPAT injected into dorsal or median raphe.
Fletcher PJ
Brain Res; 1991 Jun; 552(2):181-9. PubMed ID: 1833034
[TBL] [Abstract][Full Text] [Related]
9. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
Blier P; Serrano A; Scatton B
Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
[TBL] [Abstract][Full Text] [Related]
10. Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity.
Invernizzi R; Carli M; Di Clemente A; Samanin R
J Neurochem; 1991 Jan; 56(1):243-7. PubMed ID: 1824782
[TBL] [Abstract][Full Text] [Related]
11. A pharmacological analysis of the eating response induced by 8-OH-DPAT injected into the dorsal raphé nucleus reveals the involvement of a dopaminergic mechanism.
Fletcher PJ; Davies M
Psychopharmacology (Berl); 1990; 100(2):188-94. PubMed ID: 2137632
[TBL] [Abstract][Full Text] [Related]
12. 8-Hydroxy-2-(di-n-propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors.
Carli M; Samanin R
Br J Pharmacol; 1992 Mar; 105(3):720-6. PubMed ID: 1385752
[TBL] [Abstract][Full Text] [Related]
13. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
14. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
Currie PJ; Coscina DV; Fletcher PJ
Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
[TBL] [Abstract][Full Text] [Related]
15. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.
Goodwin GM; De Souza RJ; Green AR
Neuropharmacology; 1985 Dec; 24(12):1187-94. PubMed ID: 2869435
[TBL] [Abstract][Full Text] [Related]
16. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Yamada J; Sugimoto Y; Horisaka K
Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
[TBL] [Abstract][Full Text] [Related]
17. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
Beer M; Kennett GA; Curzon G
Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
[TBL] [Abstract][Full Text] [Related]
18. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
19. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
Hjorth S; Sharp T; Hacksell U
Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
[TBL] [Abstract][Full Text] [Related]
20. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
